Diabetes Drug Reduced Irregular Heartbeat Events in Overweight/obese Adults with AFib

Diabetes drug reduced irregular heartbeat events in overweight/obese adults with AFib

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes medication metformin in addition to standard care, according to a preliminary, late-breaking science presentation Sunday at the American Heart Association's Scientific Sessions 2025. The meeting, held Nov. 7–10 in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based cl…

Metformin reduced recurrence of atrial fibrillation after catheter ablation

NEW ORLEANS — Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when taking metformin, a generic diabetes drug, before a catheter ablation, data from a small study show.Metformin, a first-line therapy for type 2 diabetes well known for its metabolic benefits, has been associated with a decrease in AF in observational

Metformin Diabetes Drug Used Off-Label Also Reduces Irregular Heartbeats

Adults with atrial fibrillation (AFib) who are not diabetic but are overweight and took the diabetes medication metformin after a rhythm-correction procedure had decreased risk of AFib episodes for a year. Weight loss would usually be a confounder, since lifestyle changes such as that are often a big help, but in the data sample the weight changes were low.

Diabetes Drug Reduced Irregular Heartbeat Events In Overweight/obese Adults With AFib

Open the article to view the coverage from NewMediaWire